Paper Details 
Original Abstract of the Article :
BACKGROUND: Sinonasal neuroendocrine carcinoma (SNEC) is a rare, aggressive tumor usually associated with a poor prognosis. This study analyzes the clinicopathological characteristics and survival outcomes of SNEC using population-based data. METHODS: The Surveillance, Epidemiology, and End Results...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/alr.21497

データ提供:米国国立医学図書館(NLM)

Sinonasal Neuroendocrine Carcinoma: A Rare and Aggressive Desert Beast

This research explores sinonasal neuroendocrine carcinoma (SNEC), a rare and aggressive type of cancer that affects the sinuses and nasal cavity. SNEC is like a desert beast, difficult to detect and often appearing in advanced stages.

Fighting a Desert Beast: Understanding SNEC's Nature

The study analyzed data from a large database and found that SNEC patients often have a poor prognosis, particularly those with advanced stage disease. The location of the tumor also plays a role, with maxillary and ethmoid sinus cancers having a higher risk of death compared to nasal cavity cancers. The study also found that treatment with surgery, with or without radiation therapy, was associated with better survival outcomes than radiation therapy alone.

Navigating a Desert of Uncertainty: Facing SNEC

This study provides valuable insights into the characteristics and treatment of SNEC. It's like having a map of a treacherous desert, guiding us toward better strategies to combat this rare but aggressive cancer.

Dr.Camel's Conclusion

SNEC is a complex and challenging cancer. It's like navigating a vast and unforgiving desert. The study highlights the need for early detection and aggressive treatment to improve survival rates for patients diagnosed with SNEC.
Date :
  1. Date Completed 2016-02-11
  2. Date Revised 2016-05-11
Further Info :

Pubmed ID

25727332

DOI: Digital Object Identifier

10.1002/alr.21497

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.